Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Patricia R. Robuck, Mark L. Van Natta et al.|New England Journal of Medicine|2010Cited by 3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Rohit Loomba et al.|The Lancet|2014Cited by 2.2k
Endpoints and clinical trial design for nonalcoholic steatohepatitisArun J. Sanyal, Arthur J. McCullough, Elizabeth M. Brunt et al.|Hepatology|2011Cited by 757
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic SteatohepatitisJu Dong Yang, Claude B. Sirlin, Manal F. Abdelmalek et al.|Clinical Gastroenterology and Hepatology|2016Cited by 92
In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced FibrosisJonathan A. Africa, Girish Subbarao, Cynthia Behling et al.|Clinical Gastroenterology and Hepatology|2017Cited by 77